Omeros Shares Fall 15% After CHMP Upholds Negative Drug Opinion
Omeros shares fell 15% on Friday after an EMA committee upheld a negative opinion on its drug for a serious post-transplant condition. H.C. Wainwright called the selloff overdone.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.